中国学者近期发表的论文
1.	Autophagy involved in antiviral activity of sodium tanshinone IIA sulfonate against porcine reproductive and respiratory syndrome virus infection in vitro. Author: Sun N1, Sun P1, Yao M1, Khan A1, Sun Y1, Fan K2, Yin W1, Li H1. Journal: Antivir Ther. 2019;24(1):27-33. doi: 10.3851/IMP3268.    PubMed      DOI
2.	Monitoring of serum HBV RNA, HBcrAg, HBsAg and anti-HBc levels in patients during long-term nucleoside/nucleotide analogue therapy. Author: Liao H1, Liu Y2, Li X2, Wang J1, Chen X1, Zou J1, Li Q2, Liu L2, Wang J2,3, Huang B2, Lu F1, Xu D2,3. Journal: Antivir Ther. 2019;24(2):105-115. doi: 10.3851/IMP3280.    PubMed      DOI
3.	Association of serum total cholesterol with pegylated interferon-α treatment in HBeAg-positive chronic hepatitis B patients. Author: Xun Z1,2,3, Lin JP2,3, Liu C2,3, Huang JL2,3, Shen Y1,2,3, Xu SY1,2,3, Wu WN2,3, Ou QS2,3. Journal: Antivir Ther. 2019;24(2):85-93. doi: 10.3851/IMP3282.    PubMed      DOI
4.	Tenofovir plus hepatitis B immunoglobulin treatment resulted in a rapid HBV DNA load decline in high-risk pregnant women who missed the optimal time window of antiviral prophylaxis. Author: Chen T1, Liu J1, Yu Q2, Yao N1, Yang Y1, Wu Y1, Ren D1, Tian Z1, Zhao Y1, Wang J1,3. Journal: Antivir Ther. 2019;24(2):125-131. doi: 10.3851/IMP3284.    PubMed      DOI
5.	Inhibitory effect of iota-carrageenan on porcine reproductive and respiratory syndrome virus in vitro. Author: Guo C1, Zhu Z1, Yu P1, Zhang X1, Dong W1, Wang X1, Chen Y1, Liu X1. Journal: Antivir Ther. 2019 Feb 12. doi: 10.3851/IMP3295. [Epub ahead of print]    PubMed      DOI
6.	HBV reactivation during direct-acting antiviral therapy in hepatitis B and C coinfected patients undergoing haemodialysis. Author: Wang J1,2, Hu C1, Chen Y1, Liu Z1, Yu Q3, Yang S1,4, Dong J5, Yang Y1, Wu Y1, Ren D1, Yao N1, Guo D1, Tian Z1, Zhao Y1, Chen T1, He Y1, Liu J1. Journal: Antivir Ther. 2019;24(2):77-84. doi: 10.3851/IMP3292.    PubMed      DOI
7.	Peginterferon alfa-2a (40 kD) stopping rules in chronic hepatitis B: a systematic review and meta-analysis of individual participant data. Author: Pavlovic V1, Yang L2, Chan HL3, Hou J4, Janssen HL5,6, Kao JH7, Lampertico P8, Peng CY9, Piratvisuth T10, Thompson AJ11, Wedemeyer H12, Wei L13, Wat C1. Journal: Antivir Ther. 2019;24(2):133-140. doi: 10.3851/IMP3304.    PubMed      DOI
8.	Molecular cloning and phenotypic analysis of drug-resistance mutants with relevant S-region variants of HBV for a patient during 189-month anti-HBV treatment. Author: Liu Y1, Wu C2, Chen R1, Li X1, Xu Z1, Li Q1, Li L1, Wang FS1, Yang D3, Lu M4, Xu D1. Journal: Antivir Ther. 2019 Mar 18. doi: 10.3851/IMP3305. [Epub ahead of print]    PubMed      DOI
9.	Correction: Monitoring of serum HBV RNA, HBcrAg, HBsAg and anti-HBc levels in patients during long-term nucleoside/nucleotide analogue therapy. Author: Liao H1, Liu Y2, Li X2, Wang J1, Chen X1, Zou J1, Li Q2, Liu L2, Wang J2,3, Huang B2, Lu F1, Xu D2,3. Journal: Antivir Ther. 2019;24(2):151. doi: 10.3851/IMP3314.    PubMed      DOI
10.	Increased occurrence of mutant rtI233V of HBV in patients receiving adefovir therapy. Author: Liu Y, Xin S, Ye X, Chen R, Xu Z, Li X, Ye H, Cheng S, Xu D. Journal: Antivir Ther. 2016;21(1):9-16. doi: 10.3851/IMP2971. Epub 2015 Jun 16.    PubMed

同类著名期刊名称 h-index CiteScore PLoS Pathogens 174 6.02 AIDS 203 3.18 JOURNAL OF VIROLOGY 271 4.02 REVIEWS IN MEDICAL VIROLOGY 84 3.65 Retrovirology 79 3.37 ANTIVIRAL RESEARCH 108 4.19 JOURNAL OF VIRAL HEPATITIS 93 3.39 JOURNAL OF GENERAL VIROLOGY 152 2.78 Influenza and Other Respiratory Viruses 46 3.20 INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY 82 2.94

中科院JCR同大类学科的热搜期刊 浏览次数 MEDICINE 283221 CANCER RESEARCH 163417 International Journal of Nanomedicine 161787 Molecular Medicine Reports 161567 CANCER LETTERS 156850 JOURNAL OF ETHNOPHARMACOLOGY 138691 BIOMEDICINE & PHARMACOTHERAPY 136534 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY 133303 Theranostics 132486 International Journal of Environmental Research and Public Health 130965